These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19700936)

  • 1. Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma.
    Hozawa S; Haruta Y; Terada M; Yamakido M
    Allergol Int; 2009 Dec; 58(4):509-18. PubMed ID: 19700936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma.
    Wang Y; Wang CZ; Lin KX; Qian GS; Zhuo WL; Li SP; Zhao ZQ; Liao XQ; Song YX
    Respirology; 2005 Mar; 10(2):189-95. PubMed ID: 15823184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
    Katsunuma T; Fujisawa T; Nagao M; Akasawa A; Nomura I; Yamaoka A; Kondo H; Masuda K; Yamaguchi K; Terada A; Ikeda M; Nishioka K; Adachi Y; Kurihara K
    Allergol Int; 2013 Mar; 62(1):37-43. PubMed ID: 23000726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in airway inflammation and hyperresponsiveness after inhaled corticosteroid cessation in allergic asthma.
    Takaku Y; Nakagome K; Kobayashi T; Yamaguchi T; Nishihara F; Soma T; Hagiwara K; Kanazawa M; Nagata M
    Int Arch Allergy Immunol; 2010; 152 Suppl 1():41-6. PubMed ID: 20523062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
    Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
    Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
    Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
    Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, Japan.
    Ohshima N; Matsui H; Matsui Y; Kawashima M; Shimada M; Higaki N; Shoji S; Wada H; Fujita A; Watanabe H; Yamaguchi N; Matsuoka R; Oki K; Takahashi H; Suzuki M; Yamazaki H; Yoshizawa M; Goto H
    Allergol Int; 2011 Dec; 60(4):473-81. PubMed ID: 21681017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
    Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids.
    Deykin A; Lazarus SC; Fahy JV; Wechsler ME; Boushey HA; Chinchilli VM; Craig TJ; Dimango E; Kraft M; Leone F; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
    J Allergy Clin Immunol; 2005 Apr; 115(4):720-7. PubMed ID: 15805990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment.
    Ye YM; Lee HY; Kim SH; Jee YK; Lee SK; Lee SH; Park HS
    J Clin Pharm Ther; 2009 Dec; 34(6):693-701. PubMed ID: 20175803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
    Horiguchi T; Kondo R; Miyazaki J; Fukumokto K; Torigoe H
    Arzneimittelforschung; 2004; 54(5):280-5. PubMed ID: 15212190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
    Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
    J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene antagonists as first-line or add-on asthma-controller therapy.
    Price D; Musgrave SD; Shepstone L; Hillyer EV; Sims EJ; Gilbert RF; Juniper EF; Ayres JG; Kemp L; Blyth A; Wilson EC; Wolfe S; Freeman D; Mugford HM; Murdoch J; Harvey I
    N Engl J Med; 2011 May; 364(18):1695-707. PubMed ID: 21542741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.